Anthony Boral
2018
Compensation breakdown
| Non-Equity Incentive Plan | $181,482 |
|---|---|
| Option Awards | $2,037,606 |
| Salary | $447,400 |
| Other | $8,250 |
| Total | $2,674,738 |
Boral received $2M in option awards, accounting for 76% of the total pay in 2018.
Boral also received $181.5K in non-equity incentive plan, $447.4K in salary and $8.3K in other compensation.
Rankings
In 2018, Anthony Boral's compensation ranked 4,367th out of 14,244 executives tracked by ExecPay. In other words, Boral earned more than 69.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,367 out of 14,244 | 69th |
Division Manufacturing | 1,622 out of 5,765 | 72nd |
Major group Chemicals And Allied Products | 582 out of 2,128 | 73rd |
Industry group Drugs | 486 out of 1,817 | 73rd |
Industry Pharmaceutical Preparations | 378 out of 1,391 | 73rd |
Pay ratio
| Anthony Boral's Pay | $2,674,738 |
|---|---|
| Median Employee's Pay | $398,087 |
| Pay Ratio | 7to 1 |
In 2018, the annual total compensation of Anthony Boral was $2,674,738.
The annual total compensation of the median employee at Blueprint Medicines was $398,087.
The ratio of Anthony Boral's pay to the pay of median employee was therefore 7 to one.
Boral's colleagues
We found five more compensation records of executives who worked with Anthony Boral at Blueprint Medicines in 2018.
2018
Jeffrey Albers
Blueprint Medicines
Chief Executive Officer
2018
Christina Rossi
Blueprint Medicines
Chief Commercial Officer
2018
Tracey McCain
Blueprint Medicines
Chief Legal and Compliance Officer
2018
Kathryn Haviland
Blueprint Medicines
Chief Operating Officer
2018
Michael Landsittel
Blueprint Medicines